Want to see IART full AI Analyst Report?
Integra Lifesciences (IART) Income Statement
Integra Lifesciences Income Statement
Last quarter (Q3 2026), Integra Lifesciences's total revenue was $411.18M, an increase of 2.27% from the same quarter last year. In Q3, Integra Lifesciences's net income was $14.85M. See Integra Lifesciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 1.64B | $ 1.61B | $ 1.54B | $ 1.56B | $ 1.54B | |
| $ 845.23M | $ 882.06M | $ 884.74M | $ 970.31M | $ 944.64M | |
| $ 776.92M | $ 853.65M | $ 773.21M | $ 731.39M | $ 747.41M | |
| Depreciation and Amortization | $ 151.83M | $ 140.89M | $ 123.51M | $ 118.30M | $ 119.84M |
| $ -325.42M | $ 193.29M | $ 255.96M | $ 381.79M | $ 362.50M | |
| $ 68.32M | $ 28.41M | $ 111.53M | $ 238.92M | $ 197.23M | |
| $ -631.82M | $ -46.65M | $ -30.46M | $ -25.03M | $ 17.45M | |
| $ -563.50M | $ -18.24M | $ 81.07M | $ 213.89M | $ 214.68M | |
| $ -516.47M | $ -6.94M | $ 67.74M | $ 180.55M | $ 169.07M | |
| Per Share Metrics | |||||
| Basic EPS | $ -6.73 | $ -0.09 | $ 0.87 | $ 2.18 | $ 2.00 |
| Diluted EPS | $ -6.73 | $ -0.09 | $ 0.84 | $ 2.16 | $ 1.98 |
| Weighted Average Shares Outstanding | 76.75M | 77.01M | 78.17M | 83.00M | 84.70M |
| Weighted Average Shares Outstanding (Diluted) | 76.75M | 77.01M | 80.34M | 83.52M | 85.48M |
Currency in USD
